Quantum Biopharma (QNTM) Income from Continuing Operations (2019 - 2026)

Quantum Biopharma (QNTM) posted Income from Continuing Operations of 10764405.0 for Q1 2026, up 567.87% sequentially from 2300748.0 in Q4 2025, and up 102.33% YoY from 5320290.0 in Q1 2025.

Quantum Biopharma (QNTM) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Quantum Biopharma (QNTM) has 8 years of Income from Continuing Operations data on file, last reported at 10764405.0 in Q1 2026.

  • Quarterly Income from Continuing Operations rose 102.33% year-over-year to 10764405.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13237486.0 (up 350.5% YoY) and the FY2025 annual result came in at 15460437.0, up 4.38% from the prior year.
  • Income from Continuing Operations grew to 10764405.0 in Q1 2026 per QNTM's latest filing, from 2300748.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 10764405.0 in Q1 2026, with the low at 2300748.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 1630170.92, with a median of 67280.5 recorded in 2024.
  • Year-over-year, Income from Continuing Operations sank 259.4% in 2024 and jumped 4364.41% in 2025.
  • Quantum Biopharma's Income from Continuing Operations stood at 5633288.0 in 2022, then sank by 138.71% to 2180677.0 in 2023, then rose by 4.01% to 2093300.0 in 2024, then dropped by 9.91% to 2300748.0 in 2025, then soared by 567.87% to 10764405.0 in 2026.
  • Business Quant data shows QNTM's Income from Continuing Operations at 10764405.0 in Q1 2026, 2300748.0 in Q4 2025, and 22097.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 74.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -14.46 Mn
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 227.36 Mn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 1.03 Bn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -4.45 Mn
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 727.20 Mn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 378.00 Mn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 205.99 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn - -453.82 Mn
10 Quantum Biopharma 15.08 Mn 8.50 Mn - 10.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.76 Mn
Dec 31, 2025 -2.30 Mn
Sep 30, 2025 -22,097.00
Jun 30, 2025 4.80 Mn
Mar 31, 2025 5.32 Mn
Dec 31, 2024 -2.09 Mn
Sep 30, 2024 -186,485.00
Jun 30, 2024 -112,464.00
Mar 31, 2024 -178,345.00
Sep 30, 2023 -2.18 Mn
Mar 31, 2023 111,887.00
Mar 31, 2022 5.63 Mn
Jun 30, 2021 -12.71 Mn
Mar 31, 2021 9.78 Mn
Sep 30, 2020 -13.18 Mn
Jun 30, 2020 -3.53 Mn
Mar 31, 2020 3.03 Mn
Dec 31, 2019 -11.59 Mn
Sep 30, 2019 -8.50 Mn
Jun 30, 2019 -5.94 Mn